Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × mCRC × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1517 Carcinoma, Non-Small-Cell Lung 751 Breast Neoplasms 568 Neoplasm Metastasis 527 Colorectal Neoplasms 442 Melanoma 389 Leukemia, Myeloid, Acute 369 Multiple Myeloma 360 Ovarian Neoplasms 351 Recurrence 334 Lymphoma 333 Advanced Solid Tumors 318 Lymphoma, Non-Hodgkin 313 Prostatic Neoplasms 296 Pancreatic Neoplasms 286 Advanced Solid Tumor 240 Stomach Neoplasms 230 Carcinoma, Renal Cell 225 Squamous Cell Carcinoma of Head and Neck 209 Lung Neoplasms 209 Solid Tumor 202 Leukemia, Lymphocytic, Chronic, B-Cell 198 Triple Negative Breast Neoplasms 183 Solid Tumors 181 Carcinoma, Hepatocellular 161 Hematologic Neoplasms 153 Head and Neck Neoplasms 151 Lymphoma, Large B-Cell, Diffuse 147 Glioblastoma 144 Lymphoma, Follicular 143

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07543471 2026-04-21

PK equivalence

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡